Found: 34
Select item for more details and to access through your institution.
Advances in antibacterial treatment of adults with high-risk febrile neutropenia.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2109, doi. 10.1093/jac/dkad166
- By:
- Publication type:
- Article
The risk-benefit balance of resistance to ionophores in Enterococcus faecium and Enterococcus faecalis for ionophore coccidiostats in broiler chickens.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2121, doi. 10.1093/jac/dkad183
- By:
- Publication type:
- Article
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2131, doi. 10.1093/jac/dkad216
- By:
- Publication type:
- Article
Cefepime pharmacokinetics in critically ill children and young adults undergoing continuous kidney replacement therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2140, doi. 10.1093/jac/dkad192
- By:
- Publication type:
- Article
The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2148, doi. 10.1093/jac/dkad196
- By:
- Publication type:
- Article
Novel antibiotic susceptibility of an RNA polymerase α-subunit mutant in Pseudomonas aeruginosa.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2162, doi. 10.1093/jac/dkad207
- By:
- Publication type:
- Article
Making the case for precision dosing: visualizing the variability of cefepime exposures in critically ill adults.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2170, doi. 10.1093/jac/dkad211
- By:
- Publication type:
- Article
Loading dose plus continuous/extended infusion versus intermittent bolus of β-lactams for the treatment of Gram-negative bacteria bloodstream infections: a propensity score-adjusted retrospective cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2175, doi. 10.1093/jac/dkad215
- By:
- Publication type:
- Article
CHROMAgar™ LIN-R as an efficient screening tool to assess the prevalence of linezolid-resistant enterococci in German hospital patients—a multicentre study approach, 2021–2022.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2185, doi. 10.1093/jac/dkad218
- By:
- Publication type:
- Article
An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2192, doi. 10.1093/jac/dkad219
- By:
- Publication type:
- Article
Rapid expansion of Neisseria gonorrhoeae ST7827 clone in Australia, with variable ceftriaxone phenotype unexplained by genotype.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2203, doi. 10.1093/jac/dkad221
- By:
- Publication type:
- Article
Impact of veterinary antibiotics on plasmid-encoded antibiotic resistance transfer.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2209, doi. 10.1093/jac/dkad226
- By:
- Publication type:
- Article
Hospitalizations and severe complications following acute sinusitis in general practice: a registry-based cohort study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2217, doi. 10.1093/jac/dkad227
- By:
- Publication type:
- Article
Pseudomonas aeruginosa increases the susceptibility of Candida albicans to amphotericin B in dual-species biofilms.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2228, doi. 10.1093/jac/dkad228
- By:
- Publication type:
- Article
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and clinicians.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2242, doi. 10.1093/jac/dkad229
- By:
- Publication type:
- Article
Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2254, doi. 10.1093/jac/dkad230
- By:
- Publication type:
- Article
Surveillance of antimicrobial resistant Shiga toxin-producing E. coli O157:H7 in England, 2016–2020.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2263, doi. 10.1093/jac/dkad231
- By:
- Publication type:
- Article
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017–2019.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2274, doi. 10.1093/jac/dkad232
- By:
- Publication type:
- Article
Diagnostic and antibiotic stewardship lessons: an outpatient assessment of symptomatic reflex urinalysis ordering accuracy using an electronic best-practice alert.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2283, doi. 10.1093/jac/dkad233
- By:
- Publication type:
- Article
Significant increase of CTX-M-15-ST131 and emergence of CTX-M-27-ST131 Escherichia coli high-risk clones causing healthcare-associated bacteraemia of urinary origin in Spain (ITUBRAS-2 project).
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2291, doi. 10.1093/jac/dkad234
- By:
- Publication type:
- Article
Assessing the conversion of electronic medical record data into antibiotic stewardship indicators.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2297, doi. 10.1093/jac/dkad235
- By:
- Publication type:
- Article
Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2306, doi. 10.1093/jac/dkad236
- By:
- Publication type:
- Article
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2315, doi. 10.1093/jac/dkad237
- By:
- Publication type:
- Article
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2323, doi. 10.1093/jac/dkad240
- By:
- Publication type:
- Article
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2335, doi. 10.1093/jac/dkad241
- By:
- Publication type:
- Article
Imipenem/funobactam (formerly XNW4107) in vivo pharmacodynamics against serine carbapenemase-producing Gram-negative bacteria: a novel modelling approach for time-dependent killing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2343, doi. 10.1093/jac/dkad242
- By:
- Publication type:
- Article
Decay kinetics of HIV-1-RNA in seminal plasma with dolutegravir/lamivudine versus dolutegravir plus emtricitabine/tenofovir alafenamide in treatment-naive people living with HIV.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2354, doi. 10.1093/jac/dkad245
- By:
- Publication type:
- Article
Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2361, doi. 10.1093/jac/dkad247
- By:
- Publication type:
- Article
Novel SCCmec variants in clonal complex 398 and lineage-specific pseudo-SCCmec identified in ST88 MRSA from invasive bloodstream infections in China.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2366, doi. 10.1093/jac/dkad250
- By:
- Publication type:
- Article
HIV-1 RNA levels in semen of people on 'short-cycle' antiretroviral therapy.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2376, doi. 10.1093/jac/dkad197
- By:
- Publication type:
- Article
Meropenem/vaborbactam plus aztreonam for the treatment of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2377, doi. 10.1093/jac/dkad206
- By:
- Publication type:
- Article
ICE-borne erm(T)-mediated macrolide resistance in Mannheimia haemolytica.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2379, doi. 10.1093/jac/dkad209
- By:
- Publication type:
- Article
Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant: a One Health concern.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2382, doi. 10.1093/jac/dkad210
- By:
- Publication type:
- Article
Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections—authors' response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 9, p. 2385, doi. 10.1093/jac/dkad217
- By:
- Publication type:
- Article